rial boards of scientific journals and has authored more than 250 articles and book chapters. Dr. Cassell has received national and international awards and an honorary degree for her research in infectious diseases. She is a member of the Institute of Medicine (IOM) and is currently serving a 3-year term on the IOM Council, the institution’s governing board. Dr. Cassell has been intimately involved in the formulation of science policy and legislation related to biomedical research and public health. For 9 years she was chair of the Public and Scientific Affairs Board of the American Society for Microbiology; she has served as an advisor on infectious diseases and indirect costs of research to the White House Office of Science and Technology Policy, and has been an invited participant in numerous congressional hearings and briefings related to infectious diseases, antimicrobial resistance, and biomedical research. She has served two terms on the Liaison Committee on Medical Education (LCME), the accrediting body for U.S. medical schools, as well as other national committees involved in establishing policies on training in the biomedical sciences. She recently completed a term on the Leadership Council of the School of Public Health of Harvard University. Currently she is a member of the Executive Committee of the Board of Visitors of Columbia University School of Medicine, the Executive Committee of the Board of Directors of the Burroughs Wellcome Fund, Research!America, and the Advisory Council of the Johns Hopkins School of Nursing.
Peter Cegielski, M.D., M.P.H., received his bachelor’s degree with honors from Harvard University in 1978. He received his medical degree in 1984 from the University of California, San Diego School of Medicine. He completed a residency in internal medicine in 1987 and a fellowship in infectious diseases/international health in 1990, both at Duke University Medical Center. For two years he was posted to Muhimbili Medical Center, University of Dar es Salaam, Tanzania, where he was a lecturer and consultant physician. After returning to the United States, Dr. Cegielski joined the faculty of the Division of Infectious Diseases/International Health at Duke, and in 1995 he received a master’s degree in epidemiology from the University of North Carolina at Chapel Hill School of Public Health. From 1994 to 1996, he was at the University of Texas Health Science Center in Tyler, where he was an assistant professor of medicine and head of the TB service. At the end of 1996 he took a faculty position at the Johns Hopkins University School of Public Health, where he was field director of the HIV/AIDS research program at Chiang Mai University, Chiang Mai, Thailand. In 1998 he joined the International Activity of the Division of TB Elimination at CDC in Atlanta. In 2001, he was promoted to team leader for drug-resistant TB, his current position. Dr. Cegielski was a founding member of the STOP TB Green Light Committee for increasing access to